| Simplified criteria for the diagnosis of autoimmune hepatitis EM Hennes, M Zeniya, AJ Czaja, A Parés, GN Dalekos, EL Krawitt, ... Hepatology 48 (1), 169-176, 2008 | 2162 | 2008 |
| Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid A Parés, L Caballería, J Rodés Gastroenterology 130 (3), 715-720, 2006 | 889 | 2006 |
| EASL Clinical Practice Guidelines on nutrition in chronic liver disease M Merli, A Berzigotti, S Zelber-Sagi, S Dasarathy, S Montagnese, ... Journal of hepatology 70 (1), 172-193, 2019 | 798 | 2019 |
| Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid GM Hirschfield, A Mason, V Luketic, K Lindor, SC Gordon, M Mayo, ... Gastroenterology 148 (4), 751-761. e8, 2015 | 675 | 2015 |
| S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial JM Mato, J Cámara, JF De Paz, L Caballería, S Coll, A Caballero, ... Journal of hepatology 30 (6), 1081-1089, 1999 | 674 | 1999 |
| Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: the RELIEF trial R Bañares, F Nevens, FS Larsen, R Jalan, A Albillos, M Dollinger, ... Hepatology 57 (3), 1153-1162, 2013 | 633 | 2013 |
| Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study WJ Lammers, HR van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ... Gastroenterology 147 (6), 1338-1349. e5, 2014 | 514 | 2014 |
| Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial A Parés, R Planas, M Torres, J Caballería, JM Viver, D Acero, J Panés, ... Journal of hepatology 28 (4), 615-621, 1998 | 506 | 1998 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 472 | 2017 |
| Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’ U Beuers, EM Gershwin, RG Gish, P Invernizzi, DEJ Jones, K Lindor, ... Official journal of the American College of Gastroenterology| ACG 110 (11 …, 2015 | 448 | 2015 |
| Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ... Gastroenterology 149 (7), 1804-1812. e4, 2015 | 443 | 2015 |
| Short-and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial E Cabré, P Rodrı́guez-Iglesias, J Caballerı́a, JC Quer, ... Hepatology 32 (1), 36-42, 2000 | 434 | 2000 |
| Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ... Nature genetics 45 (6), 670-675, 2013 | 431 | 2013 |
| Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation KM Boberg, A Bergquist, S Mitchell, A Pares, F Rosina, U Broome, ... Scandinavian journal of gastroenterology 37 (10), 1205-1211, 2002 | 407 | 2002 |
| Histological course of alcoholic hepatitis: influence of abstinence, sex and extent of hepatic damage A Parés, J Caballería, M Bruguera, M Torres, J Rodés Journal of hepatology 2 (1), 33-42, 1986 | 355 | 1986 |
| Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial A Parés, L Caballería, J Rodés, M Bruguera, L Rodrigo, A García-Plaza, ... Journal of hepatology 32 (4), 561-566, 2000 | 352 | 2000 |
| The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ... The Lancet 399 (10319), 61-116, 2022 | 324 | 2022 |
| Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease SG Ji, BD Juran, S Mucha, T Folseraas, L Jostins, E Melum, N Kumasaka, ... Nature genetics 49 (2), 269-273, 2017 | 314 | 2017 |
| Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury A Parés, JM Barrera, J Caballería, G Ercilla, M Bruguera, L Caballería, ... Hepatology 12 (6), 1295-1299, 1990 | 299 | 1990 |
| Effects of long-term rifampicin administration in primary biliary cirrhosis L Bachs, A Parés, M Elena, C Piera, J Rodés Gastroenterology 102 (6), 2077-2080, 1992 | 290 | 1992 |
Gideon HirschfieldUniversity of TorontoZweryfikowany adres z uhn.ca
